Home › NDC Lookup › RxCUI directory › RxCUI 204602

Bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment — RxCUI 204602

Name: Bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment (RxCUI 204602)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 204602 Semantic clinical drug · SCD ● Current RxNorm concept 172 FDA products 275 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI204602

Official nameBacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment; bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment

FDA products mapped172

Package NDCs mapped275

Reported Medicaid activity (SDUD)58,778 prescriptions · 29 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Neomycin, Polymyxin, and Bacitracin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It's best for minor everyday injuries — small cuts, scrapes, and minor burns. For anything deeper, like a puncture wound or an animal bite, or for serious burns, you should check w...
Can I use this antibiotic ointment on any wound?
Stick to one week or less unless a doctor tells you otherwise. If the wound isn't improving — or gets worse — after a few days of use, that's your sign to get it looked at. You sho...
How long can I use this before I need to see a doctor?

📖 Read our full Neomycin, Polymyxin, and Bacitracin Topical guide →

🕸️ Concept Web — How Bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG /... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment RxCUI 204602 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 4

The active substance itself — no strength, form, or brand attached yet.
- Bacitracin 1291 IN
- Neomycin 7299 IN
- Polymyxin B 8536 IN
- Bacitracin / neomycin / polymyxin B 477619 MIN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Bacitracin / neomycin / polymyxin B Topical Ointment 376031 SCDF
- Bacitracin / neomycin / polymyxin B Topical Product 1155351 SCDG
- Topical Ointment 316985 DF
- Topical Product 1151122 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Bacitracin 0.4 UNT/MG 335957 SCDC
- Neomycin 0.0035 MG/MG 328185 SCDC
- Polymyxin B 5 UNT/MG 335956 SCDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Bacitracin 0.4 UNT/MG SCDC · 335957
Neomycin 0.0035 MG/MG SCDC · 328185
Polymyxin B 5 UNT/MG SCDC · 335956
Bacitracin / neomycin / polymyxin B Topical Ointment SCDF · 376031
Bacitracin / neomycin / polymyxin B Topical Product SCDG · 1155351

📦 FDA Products & Package NDCs

172 products · 275 package NDCs

275 package NDCs map to RxCUI 204602 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
80684-0140-00	14 g in 1 TUBE (80684-140-00)	Thera Plus Original Strength Triple Antibiotic	FOURSTAR GROUP USA, INC.	2025-03-03
80684-0198-00	6 PACKET in 1 BOX (80684-198-00) / .9 g in 1 PACKET	Thera Plus Original Strength Triple Antibiotic	Fourstar Group USA, Inc	2025-11-20
81417-0003-01	.9 g in 1 TUBE (81417-003-01)	Triple Antibiotic	Sled Distribution, LLC	2022-08-29
81929-0003-01	1 TUBE in 1 CARTON (81929-003-01) / 28 g in 1 TUBE	Vitacilina First Aid Antibiotic	Taisho Pharmaceutical California Inc.	2022-07-01
81929-0003-02	1 TUBE in 1 CARTON (81929-003-02) / 14 g in 1 TUBE	Vitacilina First Aid Antibiotic	Taisho Pharmaceutical California Inc.	2022-07-01
82953-0013-01	.9 g in 1 BAG (82953-013-01)	triple antibiotic 01	Cosmuses Cosmetics (Ningbo) Co., Ltd.	2024-01-04
83165-0005-00	1 PATCH in 1 PACKAGE (83165-005-00) / .9 g in 1 PATCH	First Aid Antibiotic	Hubei Fanjian Medical Product Co.,Ltd	2023-01-01
83324-0050-01	1 TUBE in 1 BOX (83324-050-01) / 28.3 g in 1 TUBE	QC Triple Antibiotic	Chain Drug Marketing Association	2024-05-24
83324-0050-05	1 TUBE in 1 BOX (83324-050-05) / 14.2 g in 1 TUBE	QC Triple Antibiotic	Chain Drug Marketing Association	2024-03-26
83807-0002-01	.9 g in 1 POUCH (83807-002-01)	EVERLIT CARE Triple Antibiotic	EVERLIT GLOBAL INC.	2023-11-14
84269-4500-01	.5 g in 1 POUCH (84269-4500-1)	Triple Antibiotic	Wildeman Business Group	2024-09-01
84387-0006-01	28.4 g in 1 TUBE (84387-006-01)	TRIPLET ANTIBIOTIC	ALLIED TRADE LINK LLC	2024-11-12
84546-0001-01	28.3 g in 1 TUBE (84546-0001-1)	ElixirTripleGuard Triple Antibiotic	ELIXIR HEALTHCARE USA, LLC.	2025-12-24
84546-0001-02	144 PACKET in 1 BOX (84546-0001-2) / .9 g in 1 PACKET	ElixirTripleGuard Triple Antibiotic	ELIXIR HEALTHCARE USA, LLC.	2025-12-24
84722-3032-00	144 OINTMENT in 1 PACKET (84722-3032-0)	TRIPLE ANTIBIOTIC	Vive Health LLC	2024-10-01
84722-3032-01	1 OINTMENT in 1 TUBE (84722-3032-1)	TRIPLE ANTIBIOTIC	Vive Health LLC	2024-09-23
84956-0009-01	1 KIT in 1 KIT (84956-009-01) * .9 g in 1 PACKET (84956-01...	Welly Polka First Aid Kit	Dongguan Shenglian Tins Products Co., Ltd.	2025-07-07
84956-0016-01	1 KIT in 1 KIT (84956-016-01) * .9 g in 1 PACKET (84956-01...	Welly First Aid Kit Refill	Dongguan Shenglian Tins Products Co., Ltd.	2026-01-05
87236-0002-01	1 TUBE in 1 CARTON (87236-002-01) / 28.4 g in 1 TUBE	Triple Antibiotic	Aldermed Inc.	2025-11-01
87236-0002-05	.5 g in 1 PACKET (87236-002-05)	Triple Antibiotic	Aldermed Inc.	2025-11-01
87236-0002-09	.9 g in 1 PACKET (87236-002-09)	Triple Antibiotic	Aldermed Inc.	2025-11-01
87236-0002-14	1 TUBE in 1 CARTON (87236-002-14) / 14.2 g in 1 TUBE	Triple Antibiotic	Aldermed Inc.	2025-11-01
87236-0002-44	144 PACKET in 1 CARTON (87236-002-44) / .9 g in 1 PACKET	Triple Antibiotic	Aldermed Inc.	2025-11-01
87236-0002-45	144 PACKET in 1 CARTON (87236-002-45) / .5 g in 1 PACKET	Triple Antibiotic	Aldermed Inc.	2025-11-01
87251-0007-01	28.3 g in 1 TUBE (87251-007-01)	oopsie First Aid	4 Visions LLC	2026-04-30

Observed labelers: Unifirst First Aid Corporation (20) · TRIFECTA PHARMACEUTICALS USA LLC (15) · Acme United Corporation (14) · HART Health (13) · Nantong Health & Beyond Hygienic Products Inc. (13) · Orazen Inc (8) · +102 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.